Category

Investing

Category

The ESC M&PD meeting brings together the world’s experts working to improve the treatment of myocarditis and pericarditis. Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular volume and a significant reduction in left ventricular mass. The Company…

Investor Insight A cycle-aware gold developer-explorer focused on value creation at the steepest part of the Lassonde Curve –…